Adoptive T cell immunotherapy using engineered lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adoptive T cell immunotherapy using engineered lymphocytes, covering 2018-03-12 to 2018-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes [Phase 1]